Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...
Main Authors: | Narasimha M. Beeraka, Surya P. Sadhu, SubbaRao V. Madhunapantula, Rajeswara Rao Pragada, Andrey A. Svistunov, Vladimir N. Nikolenko, Liudmila M. Mikhaleva, Gjumrakch Aliev |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.552925/full |
Similar Items
-
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
by: Narasimha M. Beeraka, et al.
Published: (2021-01-01) -
Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
by: John A. Lednicky, et al.
Published: (2021-07-01) -
In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01) -
The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals
by: Narasimha M. Beeraka, et al.
Published: (2020-09-01) -
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)